Exam (elaborations)
NR 293 Final Review Exam Study Questions and Answers 2024
Dobutamine (Dobutrex) -Correct Answer beta-1 selective vasoactive adrenergic drug
miscellaneous HF drug
increases cardiac output via increase contractility (positive inotropy)
increases stroke volume (esp. HF patients)
Heparin MOA -Correct Answer prevents new clots and enlargement of ...
[Show more]
Preview 3 out of 29 pages
Uploaded on
October 24, 2024
Number of pages
29
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
Institution
NR 293
Module
NR 293
£11.55
Also available in package deal from £52.24
Added
Add to cart
Add to wishlist
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
Complete Package Deal For NR 293 FINAL EXAM STUDY QUESTIONS AND ANSWERS GRADED A 2024-2025
£ 127.63
£ 52.24
12 items
1. Exam (elaborations) - Nr293 pharm workbook exam 3 answers
2. Exam (elaborations) - Pharmacology workbook: pharmacology nr293
3. Exam (elaborations) - Nr 293 exam 1 practice questions
4. Exam (elaborations) - Nr 293 pharmacology final exam review 2024 graded a
5. Exam (elaborations) - Nr 293 final pharm exam study guide questions and answers 2024-2025
6. Exam (elaborations) - Nr293 pharm exam 2 practice questions and answers 2024
7. Exam (elaborations) - Nr293 pharmacology exam study guide questions and answers with complete solutions 202...
8. Exam (elaborations) - Nr 293 final exam questions and answers graded a 2024
9. Exam (elaborations) - Nr 293 final exam study questions and answers graded a 2024-2025
10. Exam (elaborations) - Nr 293 - final exam review questions and answers top graded 2024
11. Exam (elaborations) - Nr293 pharmacology final exam review-2023 questions and answers updated 2024
12. Exam (elaborations) - Nr 293 final review exam study questions and answers 2024
Show more
NR 293 Final Review
NR 293 Final Review Exam Study
Questions and Answers 2024
Dobutamine (Dobutrex) -Correct Answer ✔beta-1 selective vasoactive adrenergic drug
miscellaneous HF drug
increases cardiac output via increase contractility (positive inotropy)
increases stroke volume (esp. HF patients)
Heparin MOA -Correct Answer ✔prevents new clots and enlargement of existing
binds to antithrombin III
inactivating several main clotting factors
-activated factor II (thrombin)
-activated factor X
-activated factor IX
Warfarin (Coumadin) MOA -Correct Answer ✔prevents clot formation
inhibits vit. K synthesis by bacteria in GI tract
inhibits clotting factors (in liver)
-II
-VII
-IX
-X
antidote for heparin -Correct Answer ✔protamine sulfate
antidote for warfarin (coumadin) -Correct Answer ✔Vit K
lab values/monitoring for heparin -Correct Answer ✔aPTT (every 6 hrs. until therapeutic
effect seen)
lab values/monitoring for warfarin (coumadin) -Correct Answer ✔prothrombin
time/international normalized ration (PT/INR)
normal INR (w/o drug) = 1
INR w/ drug = 2-3.5
NR 293 Final Review
,NR 293 Final Review
Lower INR patients >65
Aspirin adverse effects -Correct Answer ✔drowsiness
dizziness
confusion
flushing
nausea
vomiting
GI bleeding
thrombocytopenia
agranulocytosis
leukopenia
neutropenia
hemolytic anemia
bleeding
Warfarin (Coumadin) Herbal interactions -Correct Answer ✔dong quai
garlic
gingko
**increased INR = increased bleeding risk
St. Johns wart
**decreased effectiveness
Antiplatelets herbal interactions -Correct Answer ✔garlic
ginko
kava
**increased risk bleeding
Niacin (vit B3) MOA -Correct Answer ✔increase activity of lipase = breaks down lipids
reduces metabolism/catabolism cholesterol & triglycerides
inhibit lipolysis (adipose tissue)
decrease esterification triglycerides
release histamines = increases gastric motility/acid secretion
stimulate fibrinolytic system break down fibrin clots
Niacin (vit B3) indications -Correct Answer ✔lower triglycerides
lower total serum cholesterol
NR 293 Final Review
, NR 293 Final Review
lower LDL levels
increase HDL levels
treat hyperlipidemia types:
-IIa
-IIb
-III
-IV
-V
Niacin (Vit. B3) - Adverse effects -Correct Answer ✔abdominal discomfort
cutaneous flushing
pruritus
blurred vision
glucose intolerance
hepatotoxicity
Niacin (Vit B3) effects on triglyceride levels -Correct Answer ✔begin 1-4 days after
therapy
max effects 3-5 weeks continuous therapy
Niacin (Vit B3) contraindications -Correct Answer ✔liver disease
peptic ulcer disease
active hemorrhagic process
lactating women
gout
Niacin (Vit B3) interactions -Correct Answer ✔HMG-CoA (statins) = increased likelihood
myopathy development
liver dysfunction observed in sustained-release form of -Correct Answer ✔niacin
extended-release forms niacin associated w/ -Correct Answer ✔less adverse effects
(hepatoxicity & flushing)
HMG-CoA Reductase Inhibitors (Statins) Adverse effects -Correct Answer ✔headache
dizziness
blurred vision
fatigue
insomnia
constipation
diarrhea
nausea
NR 293 Final Review